|
KMID : 1231220160070020084
|
|
Journal of the Korean Society for Research on Nicotine and Tobacco
2016 Volume.7 No. 2 p.84 ~ p.90
|
|
|
Why Does the Tobacco Industry Want to Be Managed by FDA?
|
|
Lee Sung-Kyu
Kim Jin-Young
Cho Sung-Il
Cho Hong-Jun
|
|
|
Abstract
|
|
|
|
Tobacco products and the tobacco industry in Korea are managed and controlled by two laws which have different views. To solve this legal conflict and for better management and control of tobacco products and the industry, 11 Congressman submitted a motion to control the harmfulness of tobacco products in November, 2015. We found that the background and contents of the submitted law were similar with ‘Family Smoking Prevention and Tobacco Control Act’ which had become effective in the US in 2009. We reviewed the history of the Act and the arguments of US tobacco control experts on the Act. The existing studies, which analyzed the tobacco industry internal documents, described that the industry appealed their best interest to have FDA regulation. Given the reinforcing tobacco control policies around the world, tobacco industry considered FDA regulation on tobacco products as a future opportunity which allows the industry to predict future changes and run predictable business. Therefore, the industry conducted various activities, such as development of “believable explanation” to the question why the industry wanted to be managed by FDA regulation. An industry internal document we found showed Philip Morris Asia wanted to meet the Korean FDA to present their “thinking regarding development and assessment of potentially harm-reduced [tobacco] products.” Through better understanding of the US’s experience on Family Smoking Prevention and Tobacco Control Act, the Korean government and the Congress should be careful to consider the development of FDA’s management and control system on tobacco products and the industry.
|
|
|
KEYWORD
|
|
|
Tobacco, FDA, Harm reduction
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|